Special Issue: Innovations & Insights in Lymphoma
Aims & Scope
Lymphoma is one of the most common cancers, with over 500,000 new cases per year for Non-Hodgkin Lymphoma alone.
Progress in the early detection of Lymphoma is allowing patients more treatment options than in the past. New drugs, targeted therapies, and gene therapy have the potential to revolutionize the way we treat Lymphoma.
This Special Issue will focus on recent developments in our understanding of Lymphoma and possible paths towards reducing the burden of the disease.
Is membership required?
What is the Medical Research Archives?
Is there a publication charge?
Recent Lymphoma Articles
PERSONALIZED MEDICINE IN LYMPHOMA: TAILORING TREATMENT ACCORDING TO MINIMAL RESIDUAL DISEASE
How the Epidemiology of Hodgkin Lymphoma Changed in Debrecen, Hungary
Use of Obinutuzumab for B-cell Malignancies
Lacrimal Gland Orbital Lobe Cystic Mucosa-Associated Lymphoid Tissue Lymphoma
From Stem Cell Transplantation to CAR-T Therapy in Relapse-Refractory Diffuse Large B-Cell Lymphoma
Dismantling the Status Quo: Venetoclax in Mantle Cell Lymphoma
Reserve your place
Register by November 30th to contribute your article. Online registration takes less than 5 minutes.Register